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phosphoglycerate mutase (iPGM) in the filarial
parasite Brugia malayi
Prashant Kumar Singh, Susheela Kushwaha, Shahab Mohd, Manisha Pathak and Shailja Misra-Bhattacharya*Abstract
Background: The phosphoglycerate mutase (PGM) enzyme catalyzes the interconversion of 2- and 3-
phosphoglycerate in the glycolytic /gluconeogenic pathways that are present in the majority of cellular organisms.
They can be classified as cofactor-dependent PGM (dPGM) or cofactor-independent PGM (iPGM). Vertebrates, yeasts,
and many bacteria have only dPGM, while higher plants, nematodes, archaea, and many other bacteria have only
iPGM. A small number of bacteria, including Escherichia coli and certain archaea and protozoa, contain both forms.
The silencing of ipgm in Caenorhabditis elegans (C. elegans) has demonstrated the importance of this enzyme in
parasite viability and, therefore, its potential as an anthelmintic drug target. In this study, the role of the Brugia
malayi (B. malayi) ipgm in parasite viability, microfilaria release, embryogenesis, and in vivo development of infective
larvae post-gene silencing was explored by applying ribonucleic acid (RNA) interference studies.
Results: The in vitro ipgm gene silencing by small interfering RNA (siRNA) leads to severe phenotypic deformities in
the intrauterine developmental stages of female worms with a drastic reduction (~90%) in the motility of adult
parasites and a significantly reduced (80%) release of microfilariae (mf) by female worms in vitro. Almost half of the
in vitro-treated infective L3 displayed sluggish movement. The in vivo survival and development of siRNA-treated
infective larvae (L3) was investigated in the peritoneal cavity of jirds where a ~45% reduction in adult worm
establishment was observed.
Conclusion: The findings clearly suggest that iPGM is essential for both larval and adult stages of B. malayi parasite
and that it plays a pivotal role in female worm embryogenesis. The results thus validate the Bm-iPGM as a putative
anti-filarial drug target.
Keywords: siRNA, Lymphatic filariasis, Drug target, RNAi, EmbryogenesisMultilingual abstract
Please see Additional file 1 for translations of the abstract
into the six official working languages of the United
Nations.Background
Lymphatic filariasis (LF) is a vector-borne helminth
disease caused by slender nematodes, Wuchereria
bancrofti, Brugia malayi (B. malayi), and B. timori. This
incapacitating disease infects over 120 million people in
72 tropical and subtropical countries, while more than* Correspondence: shailja_cdri@rediffmail.com
Division of Parasitology, CSIR-Central Drug Research Institute, B.S. 10/1, Sector
10, Jankipuram Extension, Sitapur Road, Lucknow 226021, UP, India
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reproduction in any medium, provided the or1.39 billion people remain at the risk of infection [1].
The subclinical condition associated with patent infection
may include acute manifestations, such as adenolym-
phangitis, acute dermatolymphangioadenitis, and tropical
pulmonary eosinophilia that are rarely life threatening.
However, chronic manifestations, such as lymphedema
(elephantiasis) and hydrocele are debilitating, accounting
for nearly five million disability-adjusted life years [2,3].
Current control measures for LF include annual doses of
diethylcarbamazine or ivermectin alone, or in combi-
nation with albendazole, which principally targets micro-
filariae (mf) with little action on adult worms [4,5].
Target-based anthelmintic drug discovery is still at a nas-
cent stage and only a few drug targets have been identified
in filarial parasites utilizing this approach. The publicationtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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an expansion in transcriptomic and genomic datasets has
facilitated the identification of vital enzymes or proteins of
filarial parasites that can be exploited as drug targets. This
would further assist in the designing of potential anti-
filarial compounds and in understanding of gene functions
[6,7].
The gene silencing by ribonucleic acid (RNA) interfer-
ence (RNAi) has been a landmark discovery in the area
of biomedical research. RNAi has provided a functional
genomics platform to unravel the functions of various
genes and their associations with the disease state of the
organism. ‘Target validation’ is an inherent aspect of the
drug discovery process, which can be either accom-
plished by silencing the mRNA expression of a given
gene in situ, or by using specific inhibitors against the
target enzyme/protein to observe their deleterious effect
on that organism. With a few exceptions, RNAi has not
been utilized to its full extent in parasitic nematodes,
including in filariids [8]. RNAi in Caenorhabditis elegans
(C. elegans), a surrogate model for B. malayi, has been
explored to identify the novel genes involved in nematode
biology and comparative genomics studies have proposed
a number of molecular targets for anti-parasitic drugs [9].
Another gene identified by RNAi in C. elegans is the 2,
3-bisphosphoglycerate independent phosphoglycerate
mutase (iPGM). This enzyme's sequence and structure is
completely different from the 2, 3-bisphosphoglycerate
-dependent phosphoglycerate mutase (dPGM) found in
mammals [10]. Both enzymes are responsible for the
interconversion of 2-phosphoglycerate and 3-phospho-
glycerate via different catalytic mechanisms. The down
regulation of iPGM of C. elegans by RNAi resulted in
embryonic and larval lethality [11]. Outcomes of RNAi
experiments carried out on C. elegans do not always
match those of parasitic helminths and, therefore, it
becomes mandatory to carry out gene silencing in the tar-
get parasite itself [12]. The current investigation reports
on the RNAi mediated ipgm gene silencing in adult and
infective larval stages of human lymphatic filarial parasite,
B. malayi. Using small size (small interfering) RNA
(siRNA), the effect was observed on the parasite viability,
the mf release, the adverse effect on the embryogenesis in
the female worm, and further in vivo development of the
treated infective larvae (L3) in the adult parasites in the
peritoneal cavity of jirds.
Methods
Animals
Purpose-bred, parasite naïve, six- to eight-week old, male
jirds (Meriones unguiculatus) were used in the study.
Animals were maintained in proper housing conditions
at an animal house facility at the Central Drug Research
Institute (CDRI) in Lucknow, India, and fed a standardpellet diet and water ad libitum. The animals and the
animal experimental procedures were approved by the
Animal Ethics Committee of the Institute, duly consti-
tuted under the provisions of the Committee for the
Purpose of Control and Supervision on Experiments on
Animals (CPCSEA), Government of India. The study
bears the approval no. 129/08/Para/IAEC/renew (84/09),
dated 27.04.2009.
Parasites and culture
The B. malayi infective larvae (L3) were recovered from
the laboratory bred vector mosquito, Aedes aegypti
and fed 9 ± 1 days earlier on the donor Mastomys
(multimammate mouse-Mastomys coucha) [13]. The L3
were isolated from the gently-crushed mosquitoes using
the Baermann technique, washed repeatedly in the
Ringer’s solution, and counted. The six- to eight- week
old male jirds were infected by inoculating 100–150 L3
into the peritoneal cavity of each animal. The adult
parasites and the mf were recovered by washing the
peritoneal cavity of the jirds after 120 to 180 days of
intra-peritoneal infection. The mf were collected after
passing the peritoneal lavage through a 5.0 μm mem-
brane filter (Whatman, USA). The parasites were washed
repeatedly in the fresh culture medium RPMI 1640
(Sigma, USA) containing 100 units/ml of penicillin and
100 μg/ml of streptomycin sulfate (Invitrogen, USA),
and were transferred to an adequate volume of fresh
medium, preheated to 37°C until they were ready to be
used for RNAi experimentation. Undamaged, healthy,
similar-sized, highly motile worms of both sexes, with
females releasing almost near similar count of live mf,
were selected for the RNAi experimentation.
Design and synthesis of siRNA
The custom-designed and synthesized gene-specific
siRNAs for Bm-iPGM used in this study were procured
from Ambion, USA. The highest-ranking sense and anti-
sense siRNA duplexes representing the best combination
of activity and specificity were provided with a con-
centration of 40 nmoles as lyophilized powder. Stock
solutions of 100 μM were prepared and stored at −20°C
until use. The 50-30 sequences of the sense and antisense
strands of siRNA were:
Sense (CCA UUG UGC UGA AAC AGA Att)
Antisense (UUC UGU UUC AGC ACA AUG Gaa)
The siRNA (#AM 4621, Ambion) completely unrelated
to B. malayi, that does not target any gene product, was
used as a negative control to determine off-target effects,
if any. The negative control siRNA did not have any
sequence similarity to that of mouse, rat, or human gene
sequences, and have been pretested (Ambion) in cell-
Table 1 Criterion for motility scoring of adult worms
Motility of adult worms
% Inhibition 0 1 to 25 26 to 49 50 to 74 75 to 99 100
Score 5 4 3 2 1 Dead
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on cell proliferation, viability, or morphology.
Demonstration of in vitro siRNA uptake by parasites using
fluorescence microscopy
The penetration of siRNA into B. malayi adult females,
L3, and mf was observed after soaking the parasites in
Cy3-labelled negative siRNA. Four female worms, 50 L3,
and 100 mf were soaked in the medium containing
2 μM of siRNA separately for 24 hours at 37°C. All three
parasite stages were washed repeatedly in PBS (pH 7.4),
the fluorescence was visualized, and the parasites were
photographed under a fluorescence microscope (Nikon,
Japan) using a rhodamine filter set at an emission wave-
length of 590 nm.
siRNA treatment of B. malayi adult worms by the soaking
method
The RNAi was carried out with the adult worms of both
sexes by the soaking method. We used three groups in
our experiments. The control group did not receive any
siRNA treatment and the worms were kept in normal
siRNA-free culture medium. The negative control group
received the siRNA that was completely unrelated to
B. malayi and the third experimental group received
Bm-iPGM specific siRNA. The adult parasites (four
female and two male worms) were taken in the midi
GebaFlex tubes (cut off 5 kDa) containing 1 mM spermi-
dine, 8U RNaseOUT (Invitrogen, USA), 5 μM of siRNA
in 800 μl of RPMI medium fortified with 10% fetal
bovine serum (Invitrogen, USA) medium, and six such
tubes were kept in a beaker containing 300 ml of
medium preheated to 37°C. The beaker with the tubes
was placed in a CO2 incubator at 37°C and the tubes
were retracted at various time periods. The first tube
was removed after 12 hours of incubation and the adult
worms from the tube were transferred to a fresh siRNA-
free medium. The leftover medium in the tube was
centrifuged at 800×g for two minutes, and the pellet was
resuspended in another 50 μl medium for further obser-
vation under the compound microscope to assess the
number and phenotype of the in vitro released mf. Of
the four female worms, two were frozen in TRIzol
reagent for later preparation of nucleic acid to measure
mRNA expression of Bm-ipgm. The remaining two
females and two males were transferred to the fresh pre-
heated culture medium (37°C) for 30 minutes, and their
motility was assessed individually and scored. The viabi-
lity of each worm was subsequently checked by MTT
reduction assay using the dye 3-(4,5 dimethylthiazol-
2-yl)-2,5 diphenyltetrazolium bromide. The remaining
three tubes were removed one by one after 24 hours,
36 hours and 48 hours, and were processed in the same
way. The two leftover tubes were removed after 60 hoursof incubation. Of the eight female worms obtained from
these two tubes, two were frozen in the TRIzol reagent
for their later use in PCR, while the remaining six
females and four male worms were transferred to a fresh
siRNA-free medium and were incubated for another
48 hours by replacing the medium with fresh normal
medium every 24 hours. At the end of the experiment,
i.e. 48 hours after shifting to the siRNA-free medium,
two out of the six females were teased and their uterine
contents were observed microscopically to determine
the effect of gene silencing on embryogenesis by evalua-
ting the relative proportion of various intrauterine
progenies. The other two females were frozen in TRIzol
reagent for PCR analysis, while the remaining two
females and four male worms were checked for motility,
viability, and in vitro mf release in the culture medium
as discussed above. The experiment was repeated twice
with the same number of worms under identical condi-
tions and the data are expressed as the mean ± SD of the
two experiments.
The effect of gene silencing on the in vitro release of mf
and phenotypic changes
The mf pellets, at various time points, were suspended
in 50 μl of the PBS as mentioned above, and 10 μl of this
suspension was used in triplicate for assessing the number
of mf released in vitro. For observing the phenotypic
changes, a thin smear of mf suspension was made on a
glass slide, which was later fixed and stained with Giemsa
and photographed (Nikon, Japan).
The motility score and the viability of B. malayi adult
worms
The viability of the male and the female worms was
assessed by the mitochondrial reduction of 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT, Sigma) to formazan, as described earlier [14].
The formation of the formazan was quantified spec-
trophotometrically at 530 nm in a multiplate reader
(Tecan, Infinite M200, Switzerland), and the percent
inhibition in MTT reduction by the treated parasite
over that of control worms was assessed. The motility
scoring of the adult worms was carried out as shown
below and the percentage reduction in the motility of
the worm over that of the control was evaluated. The
worms displaying no movement even after transfer to
the fresh siRNA-free medium were considered and
scored as dead (see Table 1).
Table 2 The PCR primers used for quantitative and
RT-PCR analyses
Target Gene Primer name Primers (50-30)
Bm-ipgm Bm-ipgm F 50 GCT GAT AAG GTG ATT GAG 30
Bm-ipgm R 50 CAG TTA CCA TCA GTA TGT AG 30
Bm-tub-1 Bm-tub F 5 ACT TGG TGT CCG AAT ATC30
Bm-tub R 50ACTCTTCCTGTTCAATGTAT30
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The loss of specific transcripts following the RNAi treat-
ment was examined by real-time quantitative RT-PCR
(qRT-PCR). The B. malayi β-tubulin gene (Bm-tub-1)
was used as an endogenous control gene. For qRT-PCR,
the primers were designed with the Beacon designer
software (see Table 2). The frozen worms were homoge-
nized in the TRIzol reagent and the RNA was extracted
as described earlier [15]. The first strand cDNA was
generated using the Super Script III first strand cDNA
synthesis kit (Invitrogen, USA) using oligo (dT) 20
primers. The specific cDNA fragments were amplified
by the real-time PCR (Roche, USA) using a SYBR
premix. The PCR conditions for qRT-PCR were 95°C for
5 minutes, followed by 40 cycles of 95°C for 20 seconds,
56°C for 15 seconds, and 72°C for 30 seconds. The rela-
tive amount of target amplicon in each experiment was
determined by the comparative ΔCT method. The value
of the control group (siRNA-free medium) was set to
100%, and the relative reduction in RNAi treated groups
was calculated and expressed as percentage reductions.
The silencing of the Bm-ipgm gene in infective L3
Two hundred L3 were kept in each of the three wells of
a 48-well plate containing 1 ml culture medium fortified
with 1 mM spermidine and 8 U RNAse OUT. Of the
three wells, one contained 2 μM gene specific siRNAs,
another one contained non-target siRNA, while the third
one was devoid of siRNA. The plate was incubated at
37°C in 5% CO2 for 24 to 48 hours, and the motility of
the L3 was scored after 30 minutes of transfer to theFigure 1 Confirmation of penetration of siRNA to mf, L3, and adult fe
by all three stages of parasite in vitro after soaking for 24 hours at 2 μM co
fluorescence microscope using the rhodamine filter set at emission 590 nmfresh siRNA-free medium. The L3 that became totally
immotile and did not display any sign of reversal in the
motility after medium replenishment were considered to
be dead. The L3 from individual wells were separately
frozen in TRIzol reagent for analysis of Bm-iPGM tran-
script levels. Another set of experiments was conducted
to observe the in vivo development of in vitro siRNA
treated larvae in the naive jirds. The L3 were soaked in
the gene-specific siRNA, non-target siRNA, and control
media in the same manner as above for 24 hours,
followed by washing in the siRNA-free medium, and 100
actively motile L3 each were subsequently inoculated in
the peritoneal cavity of a 6-week old male jird. A total of
three jirds/ experiment could be inoculated with 100 L3
each as only active and live larvae were used for
infecting jirds. The jirds were euthanized after 120 days
post-infection and the parasites were isolated by
repeated washing of the peritoneal cavity. The parasites
were counted, measured, and females were later teased
individually in a drop of PBS to observe the intrauterine
development.
Statistical analysis
The data were analyzed using one-way and two-way (for
grouped data) analysis of variance (ANOVA) with the
help of statistical software PRISM 5.0. The individual
comparisons following ANOVA were made using the
Bonferroni method or the Newman-Keuls Multiple
Comparison Test, wherever applicable. The criterion of
evaluating statistical significance between the experi-
mental and control groups was as follows: p value <0.05
was considered significant and marked as *, p <0.01 as
highly significant and marked as **, and p <0.001 was
very highly significant and marked as ***.
Results
The soaking method successfully delivered the siRNA
All three parasite stages were incubated in vitro in the
presence of 2 μM concentration of Cy3-labeled negative
control siRNA to ensure the proper uptake of siRNA bymale worms. The Cy3-labeled negative control siRNA was taken up
ncentration. The fluorescence was visualized using a Nikon
.
Figure 2 The in vitro siRNA treatment of adult female B. malayi
leads to a reduction in microfilaria release. Tubes containing six
adult worms each were treated with 5 μM siRNA for different time
periods (12, 24, 36, 48, 60 hours). After 60 hours of treatment, six
females were cultured for a further two days in fresh siRNA-free
normal culture medium (108 hours). The percent reduction in the
mf release was analyzed in the Bm-iPGM-specific siRNA-treated and
negative control group over that of the control media group. There
was a significant reduction in the release of mf by Bm-iPGM siRNA-
treated worms starting from 12 hours and continuing until
108 hours. The criterion for statistical significance between the
results was carried out by ANNOVA and was expressed in the form
of p value that was considered significant and marked as p <0.05 *,
p <0.01 as highly significant **, and p <0.001 *** as very highly
significant. Data represent mean ± SE of percent reduction in mf
counts from two independent experiments.
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fully in all three stages of B. malayi at 24 hours of soaking
(see Figure 1). Fluorescence could be clearly detected at
24 hours in the hypodermis, intestine, and uterus of the
female worms, while in the L3 and mf, siRNA could be
visualized throughout the body of the filarial parasites.
The silencing of the B. malayi ipgm gene impairs the
adult B. malayi viability
The siRNA-mediated silencing of the Bm-ipgm gene by
the soaking method resulted in the reduced motility of
both male and female worms as compared to that of the
control worms, which were exposed either to the
normal, medium, or negative siRNA (see Table 3). MaleTable 3 Effect of Bm-ipgm gene silencing on adult male and f
Motility score
(female worms)
% Inhibition in MTT
reduction








12 5 5 4 2.25 ± 3.3 29.9 ± 5.4
24 5 5 3 4.5 ± 1.2 40.2 ± 6.2
36 4 5 3 5.0 ± 2.3 55.4 ± 6.3
48 4 4 2 6.2 ± 2.8 74.4 ± 3.4
108 4 4 2 6.26 ± 2.3 75.9 ± 4.7
Key: *0%: 5; 1 to 25%: 4; 26 to 49%: 3; 50 to 74%: 2; 75-99%: 1; 100%: Dead.worms were more sluggish in appearance as compared
to the female worms in the experimental groups. The
siRNA-treated parasites showed reduced viability in
MTT reduction tests, however, both the male and female
worms remained alive until the end of the experiment
(60 hours), and also after 48 hours of transfer to the
siRNA-free medium (total 108 hours). The treated
worms demonstrated a continuous decrease in their
motility with the increasing duration of incubation in
specific siRNA, and the motility data correlated well with
the inhibition in MTT reduction. Maximum inhibitions in
MTT reductions in treated female and male worms were
observed to be 75.9% and 89.4%, respectively. After
36 hours of soaking in the medium-containing target
siRNA, both sexes of adult parasites demonstrated ≥50%
inhibition in MTT reduction that exhibits a significant
adverse effect on parasite viability [16].The Bm-ipgm silencing impairs the release of mf by the
female worms, mf motility and their phenotype in vitro
The mf released by the controls and the siRNA-treated
female B. malayi in culture medium were counted. A
considerable drop was noticed in the number of mf
released by the Bm-ipgm specific siRNA-treated female
parasites within 24 hours of incubation, which decreased
further up to ~80% (p <0.001) at 48 hours, indicating a
potent adverse effect of gene silencing on mf release.
This effect remained unchanged even after transferring
these worms to a siRNA-free medium. No such pattern
was observed in the non-specific siRNA-treated control
worms (see Figure 2). In addition, a complete loss of
motility was also witnessed in ~80% of the released mf
(these appeared dead) within 24 hours of exposure and
partial paralysis was observed in the remaining 20% mf
(these seldom even had slight movement of the anterior
or posterior portion tips). The phenotypic deformities in
the mf were conspicuous by contraction of the body at
one end, leaving most of the mf sheath empty. Besides
this, a few small and large vacuoles were also visible in-
side the non-motile mf in the Bm-ipgm specific siRNA-
treated group (see Figure 3).emale B. malayi
Motility score
*(male worms)










5 5 4 2.5 ± 1.3 26.8 ± 4.5
5 5 3 4.5 ± 1.3 38.8 ± 6.5
4 4 2 4.5 ± 2.6 64.4 ± 5.4
4 4 1 6 ± 1.8 80.2 ± 6.8
4 4 1 5.25 ± 2.6 89.4 ± 5.3
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effects on female worm embryogenesis
At the end of the experiment (108 hours after initiation
of RNAi treatment), the female worms were collected
for preparing the embryogram (see Figure 4). The rela-
tive proportion of various progenies at different stages of
development that displayed good proportions of the
intrauterine contents in the form of degenerated eggsFigure 3 The Bm-ipgm specific gene silencing causes several develop
the control group (A), siRNA-free negative control group (B), and the Bm-iP
The mf from the control groups (D and E) had normal phenotypes as com
phenotypes in the mf including degenerating internal contents containing
alive (G, H), while those from the specific siRNA-treated group were dead (
from the iPGM specific siRNA (L) were degenerated, showing increased spa(~40%) was noted, and the complete morphogenesis
seemed to have failed. The remaining stages consisted of
eggs, early embryos, pretzel and, full-grown mf. The si-
lencing of the Bm-ipgm gene caused the abnormality in
the phenotypes of the eggs and the mf. All the develop-
ing stages appeared normal in the culture medium de-
void of the target siRNA, or the non-target probe (see
Figure 3).mental defects in the mf and the eggs. The Giemsa-stained mf from
GM specific siRNA-treated group (C) exhibited stretched mf sheaths.
pared to Bm-iPGM-specific siRNA treatment that led to variable
several vacuoles (F, arrows). The mf from the control groups were
I). The eggs from the control groups (J, K) were normal, while those
ces between the eggshell and the embryo.
Figure 4 The effect of siRNA on B. malayi female worm
embryogenesis. The embryograms of the female worms exposed
to the culture medium, the negative siRNA, and the Bm-iPGM
-specific siRNA (5 μM) were examined after 108 hours of incubation.
The data are expressed as percentages of eggs, early developing
stages, pretzel, and mf.
Figure 5 The percent reduction in gene transcript level in Bm-
ipgm specific siRNA treated worms. Two female worms at different
time intervals (12, 24, 36, 48, 60 hours) and 48 hours after transfer to
normal siRNA-free culture medium were removed and analyzed for
differences in Bm-ipgm gene-specific transcript levels by qRT-PCR. The
relative amounts of iPGM amplicon were determined by using the
comparative ΔCT method and normalizing against the endogenous
control gene (Bm-tub-1). The median value of the control group was
set to 100% and the reduction in expression in the treated groups was
calculated as a percentage of the control. The criterion for statistical
significance between the results was carried out by ANNOVA and was
expressed in the form of p value that was considered significant and
marked as p <0.05 *, p <0.01 as highly significant **, and p <0.001 ***
as very highly significant. Data represent mean ± SE of percent
reduction in mf counts from two independent experiments.
Singh et al. Infectious Diseases of poverty 2013, 2:5 Page 7 of 12
http://www.idpjournal.com/content/2/1/5Soaking of the adult B. malayi in the Bm-ipgm siRNA-
containing medium leads to the loss of the Bm-iPGM
transcript
The qRT-PCR results showed that the Bm-ipgm gene
silencing resulted in the transcript reduction relative to
the expression of the β-tubulin control gene within
12 hours, which continued further until 60 hours. This
reduction in the gene expression profile of the siRNA-
soaked worms was irreversible even after 48 hours of
transfer to the siRNA-free medium (see Figure 5). The
control worms revealed the presence of the Bm-iPGM
transcript at all time points of the study. The reduction
in the Bm-iPGM specific transcript level was highly
significant (p <0.001) when compared with the negative
control, which had negligible (5-8%) reduction. The data
have been represented as the percentage reduction in
the gene expression normalized using β-tubulin (Bm-
tub-1) transcript as the housekeeping gene control. The
reduction in the transcript levels correlated well with the
reduction in the release of mf from the target specific
siRNA-treated female worms, phenotypic abnormalities,
and with the complete loss of motility of the released
mf, as well as with adverse effects on the intrauterine
development.
The Bm-ipgm gene silencing in the infective L3 reduces
their motility and impairs their further development in jirds
In vitro silencing of the Bm-ipgm gene in the L3 brought
about a reduction in the motility of almost half the cul-
tured L3 at 48 hours in contrast to the control group,
where 10-12% of the L3 became sluggish. Under normal
culture conditions in the normal medium, around 25%
of the L3 became non-motile and were considered dead.
A similar effect was also observed in the target siRNA-
treated group (see Table 4) demonstrating no noticeable
adverse effects of siRNA on larval viability. However, the
gene silencing had profound adverse effects on the L3
motility leading to sluggishness but not amounting todeath within 48 hours of observation. There was ~65%
reduction in the Bm-iPGM transcript level as revealed
by the qRT-PCR of these L3 at 24 and 48 hours of obser-
vation (see Figure 6A). The surviving active and motile
L3 from all three groups from the different batches were
separately inoculated into the peritoneal cavity of the
naïve jirds to observe further in vivo development of
these L3s. There was a 44.36% reduced recovery rate
(p <0.01) of adult parasites when jirds were euthanized
on day 120, in comparison to those recovered from
control jirds (see Figure 6B). A proportion of recovered
female worms (24.9 ± 6.8%) from experimental jirds con-
tained degenerated intrauterine contents (see Figure 6C).
An interesting observation was that the relative establish-
ment of female worms was very low in the jirds infected
with the target gene specific siRNA-treated L3 in contrast
to the female worm recovery from the two control groups.
The sizes of the adult parasites were also marginally
shorter than those isolated from the control jirds (see
Table 5).
Discussion
Phosphoglycerate mutases are the enzymes that catalyze
the interconversion of 2- and 3-phosphoglycerate in the
glycolytic/gluconeogenic pathways that are present in
most cellular organisms. High-throughput RNAi studies
performed in C. elegans have identified several genes
essential for parasite viability including the cofactor-
Table 4 The effect of Bm-iPGM siRNA treatment on the morphology of infective larvae (L3)
Infective Larvae
condition
Control Negative control Bm-iPGM specific siRNA
24 h 48 h 24 h 48 h 24 h 48 h
Active (%) 82.5 ± 4.9 58.5 ± 12.0 82.5 ± 7.7 57.5 ± 9.1 49 ± 2.12 23.5 ± 9.1
Sluggish (%) 10.0 ± 2.8 17.5 ± 3.5 12.5 ± 3.5 17.0 ± 5.6 37.0 ± 2.12 50.5 ± 3.5
Dead* (%) 7.5 ± 2.2 24.0 ± 8.4 10.0 ± 2.8 25.5 ± 3.5 14.0 ± 4.24 26.0 ± 12.7
*: These were the non-motile L3 where no reversal in motility was noticed even after transfer to siRNA-free medium.
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The iPGM is present in almost all nematodes, bacteria,
and trypanosomes with the exception of some bacteria,
such as E. coli, and certain archaea and protozoa that
contain both the iPGM and dPGM forms. [21-27].
Because of its absence from the vertebrates and its key
role in pathogen development, this enzyme shows great
potential as a possible drug/vaccine candidate. In this
study, attempts were made to investigate the functional
role of the B. malayi ipgm gene in parasite viability, mf
release, embryogenesis, and in vivo infective L3 develop-
ment by RNAi mediated silencing using two important
life stages of B. malayi, the L3 and adult worms.
The RNAi was discovered accidentally in C. elegans
[28,29] and has been tried with parasitic nematodes with
variable and limited success. Nippostrongylus brasiliensis
was the first nematode for which RNAi effects were
reported using double-stranded RNAs (dsRNAs) [30] and
since then, RNAi has been reported from various other
nematodes, such as Haemonchus contortus [31-33], As-
caris suum [34-36], Trichostrongylus colubriformis [35,37],
O. volvulus [38,39], Ostertagia ostertagi [37], and B.Figure 6 Effect of siRNA on Bm-ipgm gene transcription in the L3 stag
infective larvae (L3) resulted in a significant loss of the Bm-iPGM transcript
male and female worms from the control, negative control, and Bm-ipgm-s
L3 exhibited 44.36% reduction in the adult worm establishment in the peri
control. (C) The percentage of sterile female worms recovered from contro
significant number of female worms recovered from the siRNA-treated gro
teased in a drop of PBS on glass slide and the condition of intrauterine con
female worms was calculated with respect to the total female worms reco
the results was carried out by ANNOVA and was expressed in the form of p
p <0.01 as highly significant **, and p <0.001 *** as very highly significant.
from the two independent experiments.malayi [40]. Recently, in vivo silencing has also been dem-
onstrated in Aedes aegypti, the mosquito vector of B.
malayi [41]. We have recently reported on the use of
19 bp siRNA to successfully silence B. malayi RNA heli-
case by both soaking and electroporation methods [42].
Selection of siRNAs appropriate for a given sequence
are of prime importance and are mainly based on struc-
tural attributes, such as optimal length, concentration,
the requirement of a 3’ dinucleotide overhang, and a low
G/C content [43-46]. Initially, we used 21 bp siRNA for
soaking the mf, L3, or adult worms at 2 μM concentra-
tion of Cy3-labeled, non-specific siRNA, which showed a
successful penetration of siRNA in all three parasite
stages. However, 5 μM of siRNA was used for soaking
adult parasites in our experiments, as this concentration
was effective enough to bring down the silencing effects
in our previous studies. For the gene silencing in the L3,
a lower concentration (2 μM) of siRNA was used as L3s
demonstrated better absorption of siRNA at this lower
concentration. The low concentrations and small-sized
dsRNA/siRNA have also been found to produce more
effective gene silencing effects as opposed to highe and the production of adult worms. (A) siRNA treatment of
level after 24 and 48 hours of incubation. (B) The number of recovered
pecific treated L3 implanted jirds. The Bm-ipgm-specific siRNA-treated
toneal cavity of naive male jird, which was significant (p <0.01) over
l, negative control, and Bm-ipgm-specific treated L3 implanted jirds. A
up displayed defective embryogenesis. The recovered females were
tents was analyzed microscopically (Nikon). The percentage of sterile
vered and analyzed. The criterion for statistical significance between
value that was considered significant and marked as p <0.05 *,
The data represent the mean ± SE of percent reduction in mf counts
Table 5 Measurement of worm length recovered from
jirds infected with siRNA-treated and untreated infective
larvae
Groups Worm length (cm ± S.D.)
Female Male
Control 3.47 ± 0.57 1.67 ± 0.34
Negative control 3.48 ± 0.65 1.75 ± 0.25
Bm-iPGM specific siRNA 2.60 ± 0.70 1.58 ± 0.29
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small-sized siRNA reduces the innate immune interferon
response and produces negligible non-target effects
[42,47-49]. The single siRNA was computationally
designed and custom synthesized by Ambion to target
Bm-iPGM.
Several studies have reported on off-target effects of
gene silencing and, therefore, use of more than one
siRNA has been recommended to confer effective gene
silencing. To confirm that the observed effects were
gene specific, a negative control completely unrelated to
B. malayi was used in this study. However, the use of
another siRNA specific to Bm-iPGM would have given
our results even more credibility. In previous studies, we
have used a single siRNA to target specific genes of
interest and were substantially successful in gene silen-
cing without observing any off-target effects [38,46]. The
soaking method was used, as described earlier [40,42,50],
with substantial modifications. Worms were kept in dif-
ferent tubes so that each tube could be taken out at any
time point without touching the remaining worms in the
other tubes. This was done to avoid any mechanical
damage, stress, or contamination to the remaining para-
sites requiring longer incubation. The loss of gene tran-
script level started within 12 hours of soaking in the
Bm-iPGM specific siRNA, and was apparent until the
end of the experiment, not showing any reversal even
after 48 hours of further transfer of worms to the
siRNA-free medium. The loss of gene function slowed
down the motility of both the male and female parasites.
The percent inhibition in parasite motility correlated
very well with the MTT assay, which is a quantitative
assay and has been widely used for evaluation of in vitro
anti-filarial activity of compounds against B. malayi
worms. There was a specific knockdown of the Bm-
iPGM transcript along with a range of deleterious effects
on the phenotypes, however, additional studies could not
be performed to detect the degree of protein knock-
down. This was due to the limited number of experi-
mental and control worms, and these were utilized for
assessing other parameters thought to be more import-
ant for the study.
The measurement of the mf release in the culture is a
robust method to ensure the ill effects of gene silencingon the female parasites. The profound decrease in the
number of mf released by the specific siRNA-treated
female worms indicated the deleterious effects on worm
function. The released mf revealed phenotypic defor-
mities in the form of a contracted body at one end, leav-
ing a long sheath at the other end, as well as internal
vacuole formation with subsequent loss of motility,
amounting to death. The relative proportion of various
progenies demonstrated failure of complete morphogen-
esis. The number of free mf and pretzel stages within
the uteri of the female worms showed considerable
reduction with increased proportion of early egg stages
showing impairment in the transformation of the divided
eggs into the pretzel stages. This might have been
brought about by the insufficient production of energy
needed for germ-cell differentiation since iPGM is a
crucial enzyme of the parasite glycolytic pathway. It has
been shown that mitochondrial content is regulated
during transition from different parasitic stages and
different stages have different energy requirements [51].
iPGM is involved in fundamental metabolic pathway and
has been shown in C. elegans to be expressed through-
out the worm in all the developmental stages, being
abundant in the cells with higher metabolic rates, such
as contracting body wall muscles, nerve ring, and the
intestinal cells.
The disruption of the C. elegans iPGM by RNAi
brought about variable defects, including embryonic and
larval lethality [11]. Almost half of the in vitro siRNA-
treated L3 became sluggish, while a further 25% remained
totally immotile even after transfer to normal culture
media and were thus considered ‘dead’. Even though, the
gene silencing effects were conspicuous on the motility
and viability of L3, it could not lead to their death. The
possible reason for infective L3 survival could be the
abundant storage of the iPGM enzyme in the worm body,
or the slow and sustained depletion of the iPGM tran-
script of up to 90%, but not 100%. A single concentration
of siRNA was used in the current study due to its high
cost, however, increasing the duration of the siRNA treat-
ment or the use of different concentrations of siRNA may
have possibly shown dose dependent effects on B. malayi.
A successful RNAi experiment depends on various
factors, including culture conditions, route/mode of
siRNA delivery, the gene targeted, its site, the level of
expression in the parasite, and the parasite itself. This
indicates differences between nematodes in the uptake
and the spread of dsRNA/siRNA that could have been
the reason for the variation in the results obtained with
different parasites. Silencing of the iPGM in C. elegans
had some differing outcomes that could be because of
the differences in the RNAi methodology used by us and
Zhang et al., 2004 [10]. The latter have used dsRNA
instead of siRNA, which was used in our study. The
Singh et al. Infectious Diseases of poverty 2013, 2:5 Page 10 of 12
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of different dsRNAs/siRNAs or individual transcript
sensitivities within the individual species, and this could
have been one of the reasons for the differences
observed. However, in C. elegans, the embryonic lethality
started within 18 to 24 hours, reaching a maximum of
94% at 50 to 60 hours post injection of the dsRNA.
The in vivo survival and the development of siRNA-
treated L3 was further investigated by peritoneal inocu-
lation in the naive jirds and euthanizing of the animals
on day 120 to observe the establishment of these larvae
into the adult parasites. The in vivo results demonstrated
the inability of a good proportion of the treated infective
L3s to reach adult stage. Not only this, but the
established adult worms had profound retardation in
their lengths over those who recovered from the control
groups. In addition, there was an unusually low recovery
rate of female worms, which was less than half of the
recovered males. This may be due to differential Bm-
ipgm expression patterns in male and female worms. In
one study, it has been shown that approximately 4% of
genes are associated with glycolysis and gluconeogenesis
in male worms as compared to only 1% in female worms
[52]. Thus, silencing of the ipgm might have had a more
fatal effect on the carbohydrate metabolism in female
worms resulting in their reduced recovery. The control
groups had almost twice the number of female worms
than male worms, which is quite usual in B. malayi-
infected animals. The recovered female worms from the
experimental group also displayed defective embryogen-
esis. These in vivo studies confirm the role of iPGM in
nematode metabolism, growth, and fecundity. The ad-
verse effects of iPGM gene silencing on growth have
been demonstrated earlier in a variety of plants and hu-
man parasites. The double iPGM mutants in Arabidopsis
thaliana and iPGM antisense potato plants showed
severely-retarded plant growth that correlated with
the decreased concentrations of phosphoenolpyruvate
[53,54]. The iPGM is required for the normal growth of
Trypanosoma brucei procyclic [26] and the blood stream
form [55], and has been proposed as a drug target in
spore-forming Bacillus species and tomato pathogen,
Pseudomonas syringae [56,57].
The present findings clearly demonstrate the vital role
of iPGM, a metabolic enzyme in parasite growth, and
validates Bm-iPGM as a possible anti-filarial drug target.
Conclusion
The identification and validation of anti-filarial drug
target/s is of extreme importance as there is currently
no adulticidal anti-filarial drug. RNAi has been widely
used to validate and identify such drug targets, and
PGM is one such enzyme found in two forms: verte-
brates contain the dPGM form, while the iPGM ispresent in various parasites, including filariids. The
siRNA treatment led to several phenotypic deformities
in the intrauterine stages of treated female worms. A
drastic reduction (~90%) was noticed in adult parasite
motility along with a significant reduction (80%) in the
in vitro release of mf from female worms. Almost half
the in vitro-treated L3 displayed sluggish movement.
The important aspect of the study was the observation
of in vivo survival and development of the siRNA-
treated L3 in jirds that showed ~45% reduction in the
adult worm establishment. The information obtained
from this study clearly indicates the necessity of Bm-
iPGM in the life cycle of B. malayi, and emphasizes its
major role in female worm embryogenesis. The study vali-
dates Bm-iPGM as a potent anti-filarial drug target that
can be utilized to design its novel inhibitors. Further struc-
tural and docking studies are underway to facilitate the
design and synthesis of such Bm-iPGM inhibitors that
would facilitate anti-filarial drug discovery programs.
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